Aberrant expression of epidermal growth factor receptor (EGFR) is involved in GBM initiation and progression by triggering the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling pathway [4, 5]. Here, EGFR is linked to glioblastoma.